(Q36296126)

13 August 2017

1 reference

title

Radioimmunoconjugates in acute leukemia treatment: the future is radiant (English)

1 reference

13 August 2017

1 reference

1 reference

Kotzerke J

1

1 reference

13 August 2017

Bunjes D

series ordinal

2

1 reference

13 August 2017

Scheinberg DA

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Bone Marrow Transplantation

13 August 2017

published in

1 reference

13 August 2017

volume

36

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1021-1026

1 reference

Antibody-based treatment of acute myeloid leukaemia

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Radioimmunotherapy for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

The use of radioimmunoconjugates in stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Assessment of the binding properties of Granuloszint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Tumor therapy with targeted atomic nanogenerators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

7 January 2021

The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

7 January 2021

Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

7 January 2021

Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

7 January 2021

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705182

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705182

1 reference

13 August 2017

1 reference